{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T09:55:24Z","timestamp":1790589324712,"version":"4.1.0"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Cardiac amyloidosis has emerged as an important and underrecognized cause of heart failure with preserved ejection fraction, particularly in elderly patients who commonly carry concomitant coronary artery disease. The coexistence of these two conditions creates a layered diagnostic and therapeutic problem. Epicardial atherosclerosis is present in roughly 30\u201340% of patients with cardiac amyloidosis, yet the dominant ischemic mechanism in the amyloidotic heart is rarely flow-limiting epicardial obstruction. Instead, ischemia is driven by coronary microvascular dysfunction arising from amyloid infiltration of the arteriolar wall, capillary rarefaction, extravascular compression by the hypertrophied myocardium, and in light-chain disease direct endothelial toxicity. This distinction has immediate clinical consequences. Chronic troponin elevation from subendocardial ischemia and wall stress frequently mimics acute coronary syndromes, prompting invasive procedures that carry disproportionate risk in this population, while pressure-derived indices such as fractional flow reserve are unreliable because the infiltrated microvasculature cannot mount a normal hyperemic response. This review synthesizes the pathophysiological interplay between amyloid infiltration and coronary disease, defines the diagnostic pitfalls of the dual pathology, and proposes a multimodality imaging strategy, integrating advanced echocardiography, cardiac magnetic resonance, nuclear perfusion imaging, and cardiac computed tomography that distinguishes microvascular from epicardial ischemia and supports more rational clinical decisions. Critical evidence gaps, foremost the absence of randomized data comparing revascularization with medical therapy in this population, are discussed alongside emerging tools for refining ischemic assessment in the amyloidotic heart.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mca.0000000000001679","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T09:00:12Z","timestamp":1790586012000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Cardiac amyloidosis and coronary artery disease: an overlooked clinical intersection"],"prefix":"10.1097","author":[{"given":"Jakub","family":"Kancerek","sequence":"first","affiliation":[{"name":"Student Research Group"},{"name":"Department of Histology and Cell Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Suchodolski","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Electrotherapy, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice"},{"name":"Silesian Center for Heart Diseases, Zabrze"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romuald","family":"Wojnicz","sequence":"additional","affiliation":[{"name":"Department of Histology and Cell Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariola","family":"Szulik","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Electrotherapy, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice"},{"name":"Silesian Center for Heart Diseases, Zabrze"},{"name":"Department of Medical and Health Sciences, WSB University Faculty of Applied Sciences, D\u0105browa G\u00f3rnicza"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Miszalski-Jamka","sequence":"additional","affiliation":[{"name":"Diagnostic Imaging Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Walig\u00f3ra","sequence":"additional","affiliation":[{"name":"Computed Tomography Laboratory, Silesian Center for Heart Diseases, Zabrze"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzanna","family":"Jackowska","sequence":"additional","affiliation":[{"name":"Department of Radiology and Radiodiagnostics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"G\u0142owacki","sequence":"additional","affiliation":[{"name":"Computed Tomography Laboratory, Silesian Center for Heart Diseases, Zabrze"},{"name":"Department of Radiology and Radiodiagnostics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"R1-20260928","doi-asserted-by":"crossref","first-page":"8802","DOI":"10.3390\/jcm14248802","article-title":"Coronary artery disease in cardiac amyloidosis: prevalence, clinical relevance, and cardiac magnetic resonance imaging features.","volume":"14","author":"Don\u00e0","year":"2025","journal-title":"J Clin Med"},{"key":"R2-20260928","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis.","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"R3-20260928","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/CRD.0000000000000664","article-title":"Complexities of coexisting cardiac amyloidosis and coronary artery disease: a contemporary review of diagnostic and treatment approaches.","volume":"34","author":"Lu","year":"2024","journal-title":"Cardiol Rev"},{"key":"R4-20260928","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/00015385.2021.1992990","article-title":"Cardiac amyloidosis: a review of the literature.","volume":"77","author":"de Marneffe","year":"2022","journal-title":"Acta Cardiol"},{"key":"R5-20260928","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1002\/ejhf.3481","article-title":"Microvascular obstruction in cardiac amyloidosis.","volume":"27","author":"Netti","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"R6-20260928","article-title":"Coronary microvascular dysfunction as an initial clue to the diagnosis of light-chain amyloidosis: a case report.","volume":"9","author":"Bando","year":"2025","journal-title":"Eur Heart J Case Rep"},{"key":"R7-20260928","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.3390\/jcm12062273","article-title":"Estimating the prevalence of cardiac amyloidosis in old patients with heart failure\u2014barriers and opportunities for improvement: the PREVAMIC study.","volume":"12","author":"Ruiz-Hueso","year":"2023","journal-title":"J Clin Med"},{"key":"R8-20260928","doi-asserted-by":"crossref","first-page":"102932","DOI":"10.1016\/j.cpcardiol.2024.102932","article-title":"Prevalence and outcomes of concomitant cardiac amyloidosis and coronary artery disease.","volume":"50","author":"Obi","year":"2025","journal-title":"Curr Probl Cardiol"},{"key":"R9-20260928","first-page":"52","article-title":"Chest pain and coronary artery disease in cardiac amyloidosis: prevalence, mechanisms, and clinical implications.","volume":"280","author":"Noory","year":"2025","journal-title":"BINASSS"},{"key":"R10-20260928","article-title":"Obstructive intramural coronary amyloidosis as a contributing factor to bradycardia and acute heart failure: an autopsy case.","volume":"9","author":"Kawai","year":"2025","journal-title":"Eur Heart J Case Rep"},{"key":"R11-20260928","doi-asserted-by":"crossref","first-page":"269","DOI":"10.33963\/v.phj.105217","article-title":"Coronary microvascular dysfunction in angina and non-obstructive coronary arteries: pathophysiology, diagnosis, novel markers and therapy.","volume":"83","author":"Galante","year":"2025","journal-title":"Kardiol Pol"},{"key":"R12-20260928","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.jchf.2024.07.003","article-title":"The pathophysiological and therapeutic implications of cardiac light-chain amyloidosis compared with transthyretin amyloidosis.","volume":"12","author":"Schilling","year":"2024","journal-title":"JACC Heart Fail"},{"key":"R13-20260928","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/jmri.70152","article-title":"Altered myocardial oxygenation and impaired energy efficiency: a pilot study in patients with light chain cardiac amyloidosis.","volume":"63","author":"Dai","year":"2025","journal-title":"J Magn Reson Imaging"},{"key":"R14-20260928","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40842-025-00252-6","article-title":"SGLT2 inhibitors in cardiac amyloidosis: mechanistic insights and clinical perspectives\u2014a narrative review.","volume":"11","author":"\u00d6zlek","year":"2025","journal-title":"Cardiovasc Diabetol - Endocrinol Rep"},{"key":"R15-20260928","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ejhf.3137","article-title":"Myocardial perfusion in cardiac amyloidosis.","volume":"26","author":"Chacko","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"R16-20260928","doi-asserted-by":"crossref","first-page":"531","DOI":"10.14740\/jmc2648w","article-title":"Cardiac amyloidosis presenting with myocardial ischemia: case report and literature review.","volume":"7","author":"Alvarez Keller","year":"2016","journal-title":"J Med Cases"},{"key":"R17-20260928","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.3390\/jcm13237285","article-title":"Advancing cardiac amyloidosis care through insights from cardiopulmonary exercise testing.","volume":"13","author":"Pugliatti","year":"2024","journal-title":"J Clin Med"},{"key":"R19-20260928","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases.","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"key":"R20-20260928","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/jamacardio.2021.1825","article-title":"Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.","volume":"6","author":"Rush","year":"2021","journal-title":"JAMA Cardiol"},{"key":"R21-20260928","doi-asserted-by":"crossref","first-page":"102285","DOI":"10.1016\/j.jaccas.2024.102285","article-title":"Coexistence of light chain and transthyretin cardiac amyloidosis.","volume":"29","author":"Gami","year":"2024","journal-title":"JACC Case Rep"},{"key":"R22-20260928","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jaccao.2021.09.003","article-title":"AL amyloidosis: current chemotherapy and immune therapy treatment strategies: JACC: cardiooncology state-of-the-art review.","volume":"3","author":"Bianchi","year":"2021","journal-title":"JACC CardioOncol"},{"key":"R23-20260928","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","article-title":"Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).","volume":"68","author":"Maurer","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R24-20260928","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis.","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet"},{"key":"R25-20260928","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes.","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"R26-20260928","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J"},{"key":"R27-20260928","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeae036","article-title":"Clinical characteristics of patients with high extracellular volume fraction evaluated by cardiac computed tomography for coronary artery evaluation.","volume":"4","author":"Oguni","year":"2024","journal-title":"Eur Heart J Open"},{"key":"R28-20260928","first-page":"101267","article-title":"Clinical outcomes of percutaneous coronary intervention in amyloidosis, sarcoidosis, and hemochromatosis.","volume":"3","author":"Hussain","year":"2024","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"R29-20260928","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.hrcr.2025.06.019","article-title":"Cardiac amyloid presenting as ST-elevation myocardial infarct: a case of amyloid induced coronary vasospasm.","volume":"11","author":"Gutierrez","year":"2025","journal-title":"HeartRhythm Case Rep"},{"key":"R30-20260928","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ihj.2015.08.029","article-title":"Cardiac amyloidosis presenting as recurrent acute coronary syndrome with unobstructed coronary arteries: case report.","volume":"67","author":"George","year":"2015","journal-title":"Indian Heart J"},{"key":"R31-20260928","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.hjc.2023.09.011","article-title":"High-sensitivity cardiac troponin I for cardiovascular risk stratification in apparently healthy individuals.","volume":"75","author":"Farmakis","year":"2024","journal-title":"Hellenic J Cardiol"},{"key":"R32-20260928","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth universal definition of myocardial infarction (2018).","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"R33-20260928","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaccao.2023.12.006","article-title":"Cardiac troponin in patients with light chain and transthyretin cardiac amyloidosis: JACC: CardioOncology state-of-the-art review.","volume":"6","author":"De Michieli","year":"2024","journal-title":"JACC CardioOncol"},{"key":"R34-20260928","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3390\/biomedicines13051230","article-title":"Cardiac amyloidosis: a narrative review of diagnostic advances and emerging therapies.","volume":"13","author":"Movila","year":"2025","journal-title":"Biomedicines"},{"key":"R35-20260928","first-page":"114","article-title":"Pathway for the diagnosis and management of cardiac amyloidosis.","volume":"22","author":"Herzog","year":"2023","journal-title":"Crit Pathw Cardiol"},{"key":"R36-20260928","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1056\/NEJMra1805256","article-title":"Contrast-associated acute kidney injury.","volume":"380","author":"Mehran","year":"2019","journal-title":"N Engl J Med"},{"key":"R37-20260928","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.3390\/jcm13061744","article-title":"Renal AL amyloidosis: updates on diagnosis, staging, and management.","volume":"13","author":"Shafqat","year":"2024","journal-title":"J Clin Med"},{"key":"R38-20260928","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10554-023-02806-0","article-title":"Deep learn-based computer-assisted transthoracic echocardiography: approach to the diagnosis of cardiac amyloidosis.","volume":"39","author":"Zhang","year":"2023","journal-title":"Int J Cardiovasc Imaging"},{"key":"R39-20260928","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/eurheartj\/ehp200","article-title":"Incremental value of cardiovascular magnetic resonance imaging in the differential diagnosis of hypertrophic cardiomyopathy.","volume":"30","author":"Eitel","year":"2009","journal-title":"Eur Heart J"},{"key":"R40-20260928","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1093\/eurheartj\/ehac363","article-title":"Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment.","volume":"43","author":"Martinez-Naharro","year":"2022","journal-title":"Eur Heart J"},{"key":"R41-20260928","doi-asserted-by":"crossref","first-page":"101134","DOI":"10.1016\/j.jocmr.2024.101134","article-title":"Assessing microvascular dysfunction and predicting long-term prognosis in patients with cardiac amyloidosis by cardiovascular magnetic resonance quantitative stress perfusion.","volume":"27","author":"Tang","year":"2025","journal-title":"J Cardiovasc Magn Reson"},{"key":"R42-20260928","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R43-20260928","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2-evidence base and standardized methods of imaging.","volume":"26","author":"Dorbala","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"R44-20260928","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jchf.2014.03.009","article-title":"Coronary microvascular dysfunction is related to abnormalities in myocardial blood flow and energetics in cardiac amyloidosis.","volume":"2","author":"Dorbala","year":"2014","journal-title":"JACC Heart Fail"},{"key":"R45-20260928","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jcmg.2014.09.018","article-title":"11C-Pittsburgh B PET imaging in cardiac amyloidosis.","volume":"8","author":"Lee","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"R46-20260928","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.jcmg.2018.08.023","article-title":"Stress computed tomography perfusion versus fractional flow reserve CT derived in suspected coronary artery disease: the perfection study.","volume":"12","author":"Pontone","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"R47-20260928","first-page":"362","article-title":"Invasive \u2018in the cath-lab\u2019 assessment of myocardial ischemia in patients with coronary artery disease: when does the gold standard not apply?","volume":"19","author":"Benenati","year":"2018","journal-title":"Cardiovasc Res"},{"key":"R48-20260928","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/cvr\/cvz301","article-title":"Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction.","volume":"116","author":"Konijnenberg","year":"2020","journal-title":"Cardiovasc Res"},{"key":"R49-20260928","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.carrev.2015.06.008","article-title":"Invasive assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy: the index of microvascular resistance.","volume":"16","author":"Guti\u00e9rrez-Barrios","year":"2015","journal-title":"Cardiovasc Revasc Med"},{"key":"R50-20260928","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/ehjci\/jead030","article-title":"Monitoring tafamidis treatment with quantitative SPECT\/CT in transthyretin amyloid cardiomyopathy.","volume":"24","author":"Rettl","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"R51-20260928","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3390\/ijms27020820","article-title":"Multimodal diagnosis of cardiac amyloidosis: integrating imaging, histochemistry, and proteomics for precise typing.","volume":"27","author":"Kancerek","year":"2026","journal-title":"Int J Mol Sci"},{"key":"R52-20260928","doi-asserted-by":"crossref","first-page":"e71207","DOI":"10.1002\/ccr3.71207","article-title":"Co-existing ATTR amyloidosis and coronary artery disease: a risky combination.","volume":"13","author":"Planchat","year":"2025","journal-title":"Clin Case Rep"},{"key":"R53-20260928","first-page":"454","article-title":"Coronary microvascular dysfunction: pathophysiology, diagnosis, and therapeutic strategies across cardiovascular diseases.","volume":"24","author":"Scarica","year":"2025","journal-title":"EXCLI J"},{"issue":"Suppl 1","key":"R54-20260928","doi-asserted-by":"crossref","first-page":"i88","DOI":"10.1093\/eurheartjsupp\/suae111","article-title":"Cardiac amyloidosis: Innovations in diagnosis and treatment.","volume":"27","author":"Castiglione","year":"2025","journal-title":"Eur Heart J Suppl"},{"key":"R56-20260928","article-title":"Artificial intelligence in cardiac amyloidosis: a systematic review and meta-analysis of diagnostic accuracy across imaging and non-imaging modalities.","author":"Kumbalath","year":"2025","journal-title":"medRxiv"},{"key":"R57-20260928","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.echo.2024.11.009","article-title":"Cardiac elastography with external vibration for quantification of diastolic myocardial stiffness.","volume":"38","author":"Meyer","year":"2025","journal-title":"J Am Soc Echocardiogr"},{"key":"R58-20260928","doi-asserted-by":"crossref","first-page":"103038","DOI":"10.1016\/j.cpcardiol.2025.103038","article-title":"Noninvasive assessment of myocardial stiffness using shear wave elastography in Amyloidosis and Fabry disease.","volume":"50","author":"Cafezeiro","year":"2025","journal-title":"Curr Probl Cardiol"},{"key":"R59-20260928","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/ehjci\/jeaf347","article-title":"Evaluating natural history and treatment response in cardiac amyloidosis: the evolving role of multimodality imaging.","volume":"27","author":"Walser","year":"2025","journal-title":"Eur Heart J Cardiovasc Imaging"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MCA.0000000000001679","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T09:00:20Z","timestamp":1790586020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MCA.0000000000001679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":57,"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001679","relation":{},"ISSN":["0954-6928","1473-5830"],"issn-type":[{"value":"0954-6928","type":"print"},{"value":"1473-5830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"2026-04-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}